Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sublingual immunotherapy for allergic diseases].

D Nelken

    Harefuah
    |September 9, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Sublingual immunotherapy offers a safe and effective way to treat severe allergic rhinitis and pollinosis. This method significantly improves symptoms and reduces medication reliance, with minimal side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Sublingual immunotherapy].

    Harefuah·1996
    Same author

    Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews.

    Tissue antigens·1995
    Same author

    Serologic and molecular analysis of the HLA system in Israeli Jewish patients with oral erosive lichen planus.

    Tissue antigens·1994
    Same author

    Determination of surface bound and shed HLA antigens of amniotic cells by ELISA.

    Israel journal of medical sciences·1990
    Same author

    Differential expression of HLA class-I antigens on B and T lymphocytes obtained from human lymphoid tissues.

    Immunobiology·1988
    Same author

    Human leukocyte antigens (HLA) class I and class II on sperm cells studied at the serological, cellular, and genomic levels.

    American journal of reproductive immunology and microbiology : AJRIM·1987
    Same journal

    [Tennis Elbow Among Players].

    Harefuah·2026
    Same journal

    [Internal Medicine - My Mission].

    Harefuah·2026
    Same journal

    [Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

    Harefuah·2026
    Same journal

    [Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

    Harefuah·2026
    Same journal

    [Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

    Harefuah·2026
    Same journal

    [Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

    Harefuah·2026
    See all related articles

    Area of Science:

    • Allergy and Immunology
    • Respiratory Medicine

    Background:

    • Severe allergic rhinitis and pollinosis significantly impact patient quality of life.
    • Current treatments may have limitations or side effects.

    Purpose of the Study:

    • To evaluate the efficacy and safety of sublingual immunotherapy (SLIT) for severe allergic rhinitis and pollinosis.
    • To assess the potential for reduced medication use and self-administration.

    Main Methods:

    • Patients received a commercial allergen preparation diluted in saline and albumin.
    • Dosing involved gradual increases in allergen concentration administered sublingually daily, followed by maintenance therapy.
    • Treatment duration extended up to two years with follow-up assessments.

    Main Results:

    Related Experiment Videos

    • 41 patients experienced significant clinical improvement within approximately six months.
    • A notable reduction in the need for other allergy medications was observed in all participants.
    • The procedure was well-tolerated, with practically no unwanted side effects and ease of self-administration.

    Conclusions:

    • Sublingual immunotherapy is a safe, practical, and effective treatment for severe allergic rhinitis and pollinosis.
    • SLIT demonstrates comparable results to subcutaneous allergy injections.
    • The mechanism involves increasing mucosal antibodies at the respiratory tract's allergen entry site.